48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse

Figure 4

Changes in the ratios of CD4⁺T, CD8⁺T, Th1, and Th2 in nonrelapse and virologic relapse patients.